What is the Potential of Global Anticoagulants Market? Anticoagulants are defined as the class of drugs that helps to prevent blood coagulation or increases the clotting time. They are also referred as blood thinners, but these medications actually don’t result in thinning of blood, instead helps in preventing the formation of blood clots or breaks already formed blood clots that develop in patient’s… Read More »
Demand for Patented NOACs with Prevalence of Cardiac Diseases to Drive Global Anticoagulants Drugs Market: Ken Research High prevalence of coagulation disorders, aging population, rising awareness about the available healthcare treatment options in emerging economies of Asia Pacific and Latin America and elevating healthcare spending in concurrence with GDP of the countries in these regions are the major factors which are expected to fuel the anticoagulants market globally. Anticoagulants being the… Read More »
High Incidence Rate of DVT/PE across the Globe is Expected to Fuel the Anticoagulants Market in Future Future growth of global anticoagulants market is expected to be led by high incidence rate of DVT/PE and other cardiac diseases across the globe. Bayer AG, Sanofi, Janssen Pharmaceuticals, Boehringer Ingelheim, Pfizer, Inc. and Bristol-Myers Squibb are major players operating in the market. Bayer AG is observed as the dominating players among owing to high… Read More »
Global Anticoagulants Market Outlook to 2020 – Demand for Patented NOACs with Prevalence of Cardiac Diseases to Drive Global Market Global Anticoagulants Market Outlook to 2020 – Demand for Patented NOACs with Prevalence of Cardiac Diseases to Drive Global Market” provides a comprehensive analysis of the anticoagulants market. The report includes the cumulative revenue generated by the market players from the sales of anticoagulants, including both generic and patented drugs at manufacturer’s price and market… Read More »
